BAXALTA VENTURES
Baxalta Ventures invests globally in healthcare companies developing novel products and therapies consistent with Baxaltaโs commitment to strive for excellence on behalf of patients, caregivers and healthcare providers. The Baxalta Ventures team brings unique expertise in products and therapies across the pharmaceuticals, medical devices, and biotechnology sectors. As part of Baxalta, they have access to additional expertise in product research, development, manufacturing, and commercializa... tion to their work with entrepreneurs. Baxalta Ventures believe that establishing strong relationships with entrepreneurs, other venture capital investors, and industry experts is critical for the long-term success of their portfolio companies. They aim to accelerate and enhance commercialization activities in portfolio companies by creating strategic alliances with other venture capital funds and by leveraging Baxaltaโs expertise in clinical development, production, and marketing of therapeutic solutions. Baxalta Ventures is managed by an experienced leadership team with extensive expertise in venture capital, scientific innovation, and operational leadership in the healthcare industry. Their initial investments are generally up to $5 million and may increase throughout the life of the company.
BAXALTA VENTURES
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
2015-01-01
Status:
Active
Contact:
44 (0) 20 3655 2400
Technology used in webpage:
Amazon Route 53 Pound Sterling ATT
Similar Organizations
Action Potential Venture Capital
Action Potential Venture Capital is a strategic venture capital fund that invests in bioelectronic medicine and technology companies.
Fremont Ventures
Fremont Ventures is a private investment firm specialized in network infrastructure, core technologies, and life science technologies.
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2017-06-21 | Syntimmune | Baxalta Ventures investment in Series B - Syntimmune | 50 M USD |
2016-11-17 | Syntimmune | Baxalta Ventures investment in Series A - Syntimmune | 8 M USD |
2016-03-29 | Gadeta | Baxalta Ventures investment in Series A - Gadeta | 7 M EUR |
2016-03-22 | Syntimmune | Baxalta Ventures investment in Series A - Syntimmune | 10 M USD |
2015-12-03 | True North Therapeutics | Baxalta Ventures investment in Series C - True North Therapeutics | 40 M USD |
2014-10-24 | Syntimmune | Baxalta Ventures investment in Series A - Syntimmune | 8 M USD |